K Number
K230730
Device Name
Apyx
Manufacturer
Date Cleared
2023-07-25

(131 days)

Product Code
Regulation Number
884.4530
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Apyx is intended for attaching sutures to ligaments of the pelvic floor.
Device Description
The Apyx device is indicated for anchoring sutures to ligaments of the pelvic floor. The device consists of an implantable nitinol anchor with 4 prongs configured with either non-absorbable or resorbable suture. The anchor-suture assembly is contained within a cartridge, wherein the anchor / suture assembly is deployed to the target site from the cartridge with an applicator. An optional use retriever may be used to remove the anchor in the event of sub-optimal placement of an Anchor during the index procedure. The Apyx also includes an optional securement element which may be used as a suture retention device to distribute suture tension over a larger tissue area and aid in wound healing. The Apyx device is a single use device which is supplied sterile.
More Information

Not Found

No
The device description focuses on mechanical components and surgical procedures, with no mention of AI/ML terms or functionalities.

No
The device is described as being used for "attaching sutures to ligaments of the pelvic floor" and "anchoring sutures to ligaments of the pelvic floor," which implies a mechanical function rather than a therapeutic one (e.g., healing or treating disease). Its function is to facilitate surgical repair, not to provide therapy itself.

No

The device description clearly states its purpose is for "attaching sutures to ligaments of the pelvic floor" and "anchoring sutures." It facilitates a surgical procedure (suture attachment/anchoring) rather than providing information about the presence of a disease, condition, or health status.

No

The device description clearly outlines physical components including an implantable anchor, suture, cartridge, applicator, retriever, and securement element, indicating it is a hardware-based medical device.

Based on the provided information, the Apyx device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is "for attaching sutures to ligaments of the pelvic floor." This is a surgical procedure performed in vivo (within the living body) to physically anchor sutures.
  • Device Description: The device is an implantable anchor with sutures, an applicator, and optional components for surgical use. It is used to physically manipulate tissue and secure sutures.
  • Lack of IVD Characteristics: IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue samples) in vitro (outside the body) to provide information for diagnosis, monitoring, or screening. The Apyx device does not perform any such analysis of biological samples.

The Apyx device is a surgical implant and delivery system used for a specific surgical procedure.

N/A

Intended Use / Indications for Use

The Apyx is intended for attaching sutures to ligaments of the pelvic floor.

Product codes (comma separated list FDA assigned to the subject device)

PBQ

Device Description

The Apyx device is indicated for anchoring sutures to ligaments of the pelvic floor. The device consists of an implantable nitinol anchor with 4 prongs configured with either non-absorbable or resorbable suture. The anchor-suture assembly is contained within a cartridge, wherein the anchor / suture assembly is deployed to the target site from the cartridge with an applicator. An optional use retriever may be used to remove the anchor in the event of sub-optimal placement of an Anchor during the index procedure. The Apyx also includes an optional securement element which may be used as a suture retention device to distribute suture tension over a larger tissue area and aid in wound healing.

The Apyx device is a single use device which is supplied sterile.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

ligaments of the pelvic floor

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Cadaver model testing was conducted to demonstrate that the Apyx instructions for use and critical operation tasks can be performed. Following the system instructions, users delivered the anchor through a transvaginal approach and then retrieved the applied anchors from their implantation site. No complications or unanticipated risks were observed throughout all anchor delivery and retrieval procedures. All anchors were accurately delivered into the target ligament and no damage to any of the surrounding structures was observed. All anchors were secured using the securement element and were noted to be properly fixed at the desired position with ease. It was therefore concluded that the Apyx device meets the design requirements and is suitable for its intended use.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K213783

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 884.4530 Obstetric-gynecologic specialized manual instrument.

(a)
Identification. An obstetric-gynecologic specialized manual instrument is one of a group of devices used during obstetric-gynecologic procedures to perform manipulative diagnostic and surgical functions (e.g., dilating, grasping, measuring, and scraping), where structural integrity is the chief criterion of device performance. This type of device consists of the following:(1) An amniotome is an instrument used to rupture the fetal membranes.
(2) A circumcision clamp is an instrument used to compress the foreskin of the penis during circumcision of a male infant.
(3) An umbilical clamp is an instrument used to compress the umbilical cord.
(4) A uterine curette is an instrument used to scrape and remove material from the uterus.
(5) A fixed-size cervical dilator is any of a series of bougies of various sizes used to dilate the cervical os by stretching the cervix.
(6) A uterine elevator is an instrument inserted into the uterus used to lift and manipulate the uterus.
(7) A gynecological surgical forceps is an instrument with two blades and handles used to pull, grasp, or compress during gynecological examination.
(8) A cervical cone knife is a cutting instrument used to excise and remove tissue from the cervix.
(9) A gynecological cerclage needle is a looplike instrument used to suture the cervix.
(10) A hook-type contraceptive intrauterine device (IUD) remover is an instrument used to remove an IUD from the uterus.
(11) A gynecological fibroid screw is an instrument used to hold onto a fibroid.
(12) A uterine sound is an instrument used to determine the depth of the uterus by inserting it into the uterine cavity.
(13) A cytological cervical spatula is a blunt instrument used to scrape and remove cytological material from the surface of the cervix or vagina.
(14) A gynecological biopsy forceps is an instrument with two blades and handles used for gynecological biopsy procedures.
(15) A uterine tenaculum is a hooklike instrument used to seize and hold the cervix or fundus.
(16) An internal pelvimeter is an instrument used within the vagina to measure the diameter and capacity of the pelvis.
(17) A nonmetal vaginal speculum is a nonmetal instrument used to expose the interior of the vagina.
(18) A fiberoptic nonmetal vaginal speculum is a nonmetal instrument, with fiberoptic light, used to expose and illuminate the interior of the vagina.
(b)
Classification. (1) Class II (special controls). The device, when it is an umbilical clamp with or without a cutter, a uterine tenaculum which is sterile and does not use suction and is intended for single use, a nonmetal vaginal speculum, or a fiberoptic nonmetal vaginal speculum, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.(2) Class I for the amniotome, uterine curette, cervical dilator (fixed-size bougies), cerclage needle, IUD remover, uterine sound, and gynecological biopsy forceps. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 884.9.

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

July 25, 2023

Escala Medical % Lina R. Kontos Partner Hogan Lovells 555 Thirteenth Street. NW Washington, DC 20004-1109

Re: K230730

Trade/Device Name: Apyx Regulation Number: 21 CFR§ 884.4530 Regulation Name: Obstetric-Gynecologic Specialized Manual Instrument Regulatory Class: II Product Code: PBQ Dated: June 26, 2023 Received: June 27, 2023

Dear Lina R. Kontos:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies.combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

1

Page 2

You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrl-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Reginald K. Avery -S

Jason R. Roberts, Ph.D. Assistant Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K230730

Device Name Арух

Indications for Use (Describe)

The Apyx is intended for attaching sutures to ligaments of the pelvic floor.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510(k) SUMMARY

Escala Apyx

Submitter

Escala Medical LTD. 17 Tchelet St. Misgav Business Park 2017400 Israel

Phone: +972.72.260.7000

Contact Person: Edit Goldberg, CEO

Date Prepared: July 13, 2023

Name of Device: Apyx

Common or Usual Name: Fixation device for the pelvic floor

Classification Number: 884.4530

Classification Name: Obstetric-gynecologic specialized manual instrument

Requlatory Class: II

Product Code: PBQ

Product Code Name: Fixation, Non-Absorbable or Absorbable, For Pelvic Use

Predicate Device: Escala Medical Ltd., Apyx, K213783

The predicate device has not been subject to a design-related recall.

Device Description

The Apyx device is indicated for anchoring sutures to ligaments of the pelvic floor. The device consists of an implantable nitinol anchor with 4 prongs configured with either non-absorbable or resorbable suture. The anchor-suture assembly is contained within a cartridge, wherein the anchor / suture assembly is deployed to the target site from the cartridge with an applicator. An optional use retriever may be used to remove the anchor in the event of sub-optimal placement of an Anchor during the index procedure. The Apyx also includes an optional securement element which may be used as a suture retention device to distribute suture tension over a larger tissue area and aid in wound healing.

The Apyx device is a single use device which is supplied sterile.

Intended Use / Indications for Use

The Apyx is intended for attaching sutures to ligaments of the pelvic floor.

4

Summary of Technological Characteristics

Both the subject and predicate devices are indicated for attaching sutures to ligaments of the pelvic floor. The technological characteristics of the Apyx are identical to that of the previously cleared Apyx device, i.e., the predicate devices include a nitinol anchor, which is provided with the attached suture and delivered using an applicator. The devices are supplied sterile by ethylene oxide and are pre-loaded with the anchor-suture assembly. The difference between the subject device and the predicate device is the inclusion of the securement. The inclusion of this optional component is evaluated with similar testing as the predicate device and accordingly does not raise different questions of safety or effectiveness.

| | Subject Device
Apyx (K230730) | Predicate Device
Apyx (K213783) |
|------------------------------|------------------------------------------------------------|--------------------------------------------------|
| Anchor design | 4 prongs | 4 prongs |
| Anchor materials | Nitinol and optional stainless
steel securement element | Nitinol |
| Suture | Polypropylene or
Polydioxanone | Polypropylene or
Polydioxanone |
| Applicator | Yes - shaft (applicator
cartridge) and handle | Yes – shaft (applicator
cartridge) and handle |
| Securement element | Yes (optional - per physician
discretion) | No |
| Retriever for device removal | Yes (optional – per physician
discretion) | Yes (optional - per physician
discretion) |

Performance Data

Testing to support the modified device with the optional securement included:

  • . Biocompatibility testing in accordance with the 2020 FDA quidance document Use of International Standard ISO 10993-1. "Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process" and ISO 10993 consistent with intended duration of contact:
    • Cytotoxicity o
    • O Sensitization
    • Pyrogenicity O
    • Irritation O
    • Intracutaneous reactivity O
  • . Chemical Characterization and toxicological risk assessment in accordance with ISO 10993-18 to address biocompatibility endpoints of:
    • O Genotoxicity
    • O Acute systemic toxicity
    • Chronic systemic toxicity O
    • Carcinogenicity O
    • Developmental/reproductive toxicity O
  • Corrosion resistance ●
  • Packaging validation
  • Shelf-life validation ●
  • Securement element pull out

5

Cadaver Testing

Cadaver model testing was conducted to demonstrate that the Apyx instructions for use and critical operation tasks can be performed. Following the system instructions, users delivered the anchor through a transvaginal approach and then retrieved the applied anchors from their implantation site. No complications or unanticipated risks were observed throughout all anchor delivery and retrieval procedures. All anchors were accurately delivered into the target ligament and no damage to any of the surrounding structures was observed. All anchors were secured using the securement element and were noted to be properly fixed at the desired position with ease. It was therefore concluded that the Apyx device meets the design requirements and is suitable for its intended use.

Conclusions

The Apyx has the same intended use and identical indications, and substantially similar technological characteristics, and principles of operation as its predicate device. The sole difference between the Apyx and its predicate device (optional securement element) does not raise any different questions of safety or effectiveness. Performance data demonstrates that the Apyx with the optional securement element is as safe and effective as the predicate device to support a substantial equivalence determination.